Managing muscle-invasive bladder cancer in the elderly

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J. Clin.59(4), 225–249 (2009).
   PubMed Web of Science ®Google Scholar
• Schultzel M, Saltzstein SL, Downs TM, Shimasaki S, Sanders C, Sadler GR. Late age (85 years or older) peak incidence of bladder cancer. J. Urol.179(4), 1302–1305 (2008).
   PubMedGoogle Scholar
• Cooksley CD, Avritscher EB, Grossman HB et al. Clinical model of cost of bladder cancer in the elderly. Urology71(3), 519–525 (2008).
   PubMed Web of Science ®Google Scholar
• Hollenbeck BK, Ye Z, Dunn RL, Montie JE, Birkmeyer JD. Provider treatment intensity and outcomes for patients with early-stage bladder cancer. J. Natl Cancer Inst.101(8), 571–580 (2009).
   PubMedGoogle Scholar
• Lee CT, Dunn RL, Ingold C, Montie JE, Wood DP Jr. Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion. Urology69(6), 1068–1072 (2007).
   PubMed Web of Science ®Google Scholar
• Pope D, Ramesh H, Gennari R et al. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg. Oncol.15(4), 189–197 (2006).
   PubMedGoogle Scholar
• Prasad SM, Ferreria M, Berry AM et al. Surgical apgar outcome score: perioperative risk assessment for radical cystectomy. J. Urol.181(3), 1046–1052 (2009).
   PubMed Web of Science ®Google Scholar
• Glascock AP, Feinman SL. A holocultural analysis of old age. Comp. Soc. Res.3, 311–332 (1980).
   Google Scholar
• Ouslander JG, Beck JC. Defining the health problems of the elderly. Ann. Rev. Public Health3, 55–83 (1982).
   PubMedGoogle Scholar
• Roebuck J. When does old age begin?: The evolution of the English definition. J. Soc. Hist.12(3), 416–428 (1979).
   Web of Science ®Google Scholar
• Crews DE, Zavotka S. Aging, disability, and frailty: implications for universal design. J. Physiol. Anthropol.25(1), 113–118 (2006).
   PubMedGoogle Scholar
• Carreca I, Balducci L. Cancer chemotherapy in the older cancer patient. Urol. Oncol.27(6), 633–642 (2009).
   PubMed Web of Science ®Google Scholar
• Shariat SF, Milowsky M, Droller MJ. Bladder cancer in the elderly. Urol. Oncol.27(6), 653–667 (2009).
   PubMed Web of Science ®Google Scholar
• Taylor JA III, Kuchel GA. Bladder cancer in the elderly: clinical outcomes, basic mechanisms, and future research direction. Nat. Clin. Pract. Urol.6(3), 135–144 (2009).
   PubMedGoogle Scholar
• Balducci L, Extermann M. A practical approach to the older patient with cancer. Curr. Probl. Cancer25(1), 6–76 (2001).
   PubMedGoogle Scholar
• Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci.56(3), M146–M156 (2001).
   PubMed Web of Science ®Google Scholar
• Ramesh HS, Boase T, Audisio RA. Risk assessment for cancer surgery in elderly patients. Clin. Interv. Aging1(3), 221–227 (2006).
   PubMed Web of Science ®Google Scholar
• Koupparis A, Pickard A, Lewis S, Rowe E. Preoperative assessment for major urological surgery: where are we now? BJU Int.104(3), 288–290 (2009).
   PubMedGoogle Scholar
• Older P, Hall A, Hader R. Cardiopulmonary exercise testing as a screening test for perioperative management of major surgery in the elderly. Chest116(2), 355–362 (1999).
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol.19(3), 666–675 (2001).
   PubMed Web of Science ®Google Scholar
• Herr HW. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology61(1), 105–108 (2003).
   PubMed Web of Science ®Google Scholar
• Stein JP, Penson DF, Cai J et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J. Urol.177(3), 876–881 (2007).
   PubMed Web of Science ®Google Scholar
• Sasako M, Sano T, Yamamoto S et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N. Engl. J. Med.359(5), 453–462 (2008).
   PubMed Web of Science ®Google Scholar
• Blom JH, van Poppel H, Marechal JM et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized Phase III trial 30881. Eur. Urol.55(1), 28–34 (2009).
   PubMed Web of Science ®Google Scholar
• Froehner M, Brausi MA, Herr HW, Muto G, Studer UE. Complications following radical cystectomy for bladder cancer in the elderly. Eur. Urol.56(3), 443–454 (2009).
   PubMed Web of Science ®Google Scholar
• Hollenbeck BK, Miller DC, Taub D et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology64(2), 292–297 (2004).
   PubMed Web of Science ®Google Scholar
• Shariat SF, Karakiewicz PI, Palapattu GS et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin. Cancer Res.12(22), 6663–6676 (2006).
   PubMed Web of Science ®Google Scholar
• Farnham SB, Cookson MS, Alberts G, Smith JA Jr, Chang SS. Benefit of radical cystectomy in the elderly patient with significant co-morbidities. Urol. Oncol.22(3), 178–181 (2004).
   PubMed Web of Science ®Google Scholar
• Clark PE, Stein JP, Groshen SG et al. Radical cystectomy in the elderly: comparison of clinical outcomes between younger and older patients. Cancer104(1), 36–43 (2005).
   PubMed Web of Science ®Google Scholar
• Koppie TM, Serio AM, Vickers AJ et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer112(11), 2384–2392 (2008).
   PubMed Web of Science ®Google Scholar
• Dash A, Galsky MD, Vickers AJ et al. Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. Cancer107(3), 506–513 (2006).
   PubMed Web of Science ®Google Scholar
• Weizer AZ, Joshi D, Daignault S et al. Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer. J. Urol.177(4), 1287–1293 (2007).
   PubMedGoogle Scholar
• Figueroa AJ, Stein JP, Dickinson M et al. Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer83(1), 141–147 (1998).
   PubMed Web of Science ®Google Scholar
• Peyromaure M, Guerin F, Debre B, Zerbib M. Surgical management of infiltrating bladder cancer in elderly patients. Eur. Urol.45(2), 147–153 (2004).
   PubMed Web of Science ®Google Scholar
• Mendiola FP, Zorn KC, Gofrit ON et al. Cystectomy in the ninth decade: operative results and long-term survival outcomes. Can. J. Urol.14(4), 3628–3634 (2007).
   PubMedGoogle Scholar
• May M, Fuhrer S, Braun KP et al. Results from three municipal hospitals regarding radical cystectomy on elderly patients. Int. Braz. J. Urol.33(6), 764–773 (2007).
   PubMedGoogle Scholar
• Fairey A, Chetner M, Metcalfe J et al. Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database. J. Urol.180(1), 128–134 (2008).
   PubMedGoogle Scholar
• Navon JD, Wong AK, Weinberg AC, Ahlering TE. A comparative study of postoperative complications associated with the modified Indiana pouch in elderly versus younger patients. J. Urol.154(4), 1325–1328 (1995).
   PubMedGoogle Scholar
• Sogni F, Brausi M, Frea B et al. Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology71(5), 919–923 (2008).
   PubMed Web of Science ®Google Scholar
• Gilbert SM, Wood DP, Dunn RL et al. Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI). Cancer109(9), 1756–1762 (2007).
   PubMed Web of Science ®Google Scholar
• Gore JL, Saigal CS, Hanley JM, Schonlau M, Litwin MS. Variations in reconstruction after radical cystectomy. Cancer107(4), 729–737 (2006).
   PubMed Web of Science ®Google Scholar
• Deliveliotis C, Papatsoris A, Chrisofos M, Dellis A, Liakouras C, Skolarikos A. Urinary diversion in high-risk elderly patients: modified cutaneous ureterostomy or ileal conduit? Urology66(2), 299–304 (2005).
   PubMedGoogle Scholar
• Chade DC, Laudone VP, Bochner BH, Parra RO. Oncological outcomes after radical cystectomy for bladder cancer: open versus minimally invasive approaches. J. Urol.183(3), 862–869 (2010).
   PubMedGoogle Scholar
• Guillotreau J, Game X, Mouzin M et al. [Laparoscopic radical cystectomy in elderly patients with bladder cancer: feasibility and evaluation of morbidity]. Prog. Urol.20(3), 204–209 (2010).
   PubMed Web of Science ®Google Scholar
• Capitanio U, Isbarn H, Shariat SF et al. Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist. Urology74(4), 858–864 (2009).
   PubMed Web of Science ®Google Scholar
• Kassouf W, Swanson D, Kamat AM et al. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. J. Urol.175(6), 2058–2062 (2006).
   PubMed Web of Science ®Google Scholar
• Tai HC, Chung SD, Wang SM, Chueh SC, Yu HJ. Laparoscopic partial cystectomy for various bladder pathologies. BJU Int.100(2), 382–385 (2007).
   PubMedGoogle Scholar
• Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet374(9685), 239–249 (2009).
   PubMed Web of Science ®Google Scholar
• Efstathiou JA, Bae K, Shipley WU et al. Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89–03, 95–06, 97–06, 99–06. J. Clin. Oncol.27(25), 4055–4061 (2009).
   PubMed Web of Science ®Google Scholar
• Higano CS, Tangen CM, Sakr WA et al. Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733. Cancer112(10), 2181–2187 (2008).
   PubMed Web of Science ®Google Scholar
• Sandhu A, Mundt AJ. Radiation therapy for urologic malignancies in the elderly. Urol. Oncol.27(6), 643–652 (2009).
   PubMedGoogle Scholar
• Tran E, Souhami L, Tanguay S, Rajan R. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer. Am. J. Clin. Oncol.32(4), 333–337 (2009).
   PubMed Web of Science ®Google Scholar
• Solsona E, Iborra I, Ricos JV, Monros JL, Casanova J, Calabuig C. Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term followup of a prospective study. J. Urol.159(1), 95–98 (1998).
   PubMed Web of Science ®Google Scholar
• Leibovici D, Kassouf W, Pisters LL et al. Organ preservation for muscle-invasive bladder cancer by transurethral resection. Urology70(3), 473–476 (2007).
   PubMedGoogle Scholar
• Bamias A, Lainakis G, Kastritis E et al. Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment. Oncology73(5–6), 290–297 (2007).
   PubMedGoogle Scholar
• Castagneto B, Zai S, Marenco D et al. Single-agent gemcitabine in previously untreated elderly patients with advanced bladder carcinoma: response to treatment and correlation with the comprehensive geriatric assessment. Oncology67(1), 27–32 (2004).
   PubMedGoogle Scholar
• Resorlu B, Beduk Y, Baltaci S, Ergun G, Talas H. The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int.103(4), 480–483 (2009).
   PubMed Web of Science ®Google Scholar
• Nielsen ME, Shariat SF, Karakiewicz PI et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur. Urol.51(3), 699–706 (2007).
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Miyake H, Hara I, Inoue TA, Fujisawa M. Significance of radical cystectomy for bladder cancer in patients over 80 years old. Int. Urol. Nephrol.39(1), 209–214 (2007).
   PubMed Web of Science ®Google Scholar
• Game X, Soulie M, Seguin P et al. Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur. Urol.39(5), 525–529 (2001).
   PubMedGoogle Scholar
• Soulie M, Straub M, Game X et al. A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer. J. Urol.167(3), 1325–1328 (2002).
   PubMed Web of Science ®Google Scholar
• Bostrom PJ, Kossi J, Laato M, Nurmi M. Risk factors for mortality and morbidity related to radical cystectomy. BJU Int.103(2), 191–196 (2009).
   PubMed Web of Science ®Google Scholar
• Prout GR Jr, Wesley MN, Yancik R, Ries LA, Havlik RJ, Edwards BK. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer104(8), 1638–1647 (2005).
   PubMed Web of Science ®Google Scholar
• Stroumbakis N, Herr HW, Cookson MS, Fair WR. Radical cystectomy in the octogenarian. J. Urol.158(6), 2113–2117 (1997).
   PubMed Web of Science ®Google Scholar
• Zebic N, Weinknecht S, Kroepfl D. Radical cystectomy in patients aged > or = 75 years: an updated review of patients treated with curative and palliative intent. BJU Int.95(9), 1211–1214 (2005).
   PubMed Web of Science ®Google Scholar
• Tilki D, Zaak D, Trottmann M et al. Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series. World J. Urol. DOI: 10.1007/s00345-009-0482-1 (2009) (Epub ahead of print).
   PubMedGoogle Scholar